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Abstract
Our aim was to investigate whether combining two powerful antioxidants such as Trolox and Quercetin could 
enhance their toxicity against breast and ovarian cancer cells. Human ovarian carcinoma cells from the A2780 
line and human mammary gland carcinoma cells belonging to the T47D-KBluc line were incubated in RPMI-1640 
supplemented with 50 µM Trolox and various Quercetin concentrations (25 µM, 50 µM and 100 µM). After 24 
hours, several test were conducted: cells were stained with trypan blue and the number of viable versus dead cells 
was counted; cells were stained with Hoechst 33258 and propidium iodide to investigate the incidence of apoptosis 
and necrosis; cell activity and proliferation was assessed using the MTT test. In the A2780 line 50 µM Trolox + 
25µM Quercetin increased the number of apoptotic cells and enzyme activity in these cells, without influencing 
viability. On the other hand, in the T47D-KBluc line the 50 µM Trolox + 100 µM combination enhanced necrosis 
and thus reduced the percentages of metabolically active cells. Together with this concentration, a mix made of 50 
µM Trolox and 25 µM Quercetin also reduced cell viability. Our research indicates that in combination with Trolox, 
low concentrations of Quercetin induce apoptosis in human ovarian cancer cells, while high concentrations induce 
necrosis in human breast cancer cells. Quercetin concentrations influence this response significantly. Combining 
Quercetin with Trolox can enhance their toxicity against breast and ovarian cancer cells.
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INTRODUCTION
Breast cancer is one of the most common 
malignancies and it has a serious impact on female 
health (Deng et al., 2013). Worldwide, it is the 
most frequently diagnosed cancer and the leading 
cause of cancer death among females (Torre et al., 
2012). Ovarian cancer is the most frequent cause 
of death among women with malignancies of the 
genital system (Siegel et al., 2015).
Despite the development of surgical 
techniques and chemotherapy, relapses occur 
very often especially in advanced cases (Deng et 
al., 2013). Therefore, the development of new 
antitumor substances is of paramount importance 
in the ongoing war against cancer. Some of the 
most widely employed chemotherapeutic drugs 
have been discovered and then perfected starting 
from natural sources (Cragg et al., 2011).
Among naturally occurring chemicals, 
flavonoids are considered promising food-derived 
chemo-preventive but also therapeutic agents 
against various human cancers (Sak, 2014). 
Quercetin, a naturally occurring flavonol, is one 
of the most abundant flavonoids found in many 
fruits and vegetables, such as broccoli, yellow 
onions, and apples (Boots et al., 2008). Some of 
its biological effects on both cancer and normal 
cells have been studied (reviewed in Gibellini et 
al., 2011). Previous in vitro research has shown that Quercetin acts as an antioxidant and anti-
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inflammatory agent and that it has potent anti-
carcinogenic properties as apoptosis inductor 
(Akan and Grip, 2013). Its activities include cell 
cycle regulation, interaction with type II estrogen 
binding sites and tyrosine kinase inhibition 
(Lamson and Brignall, 2001).
Trolox, the hydrophilic analogue of 
α-tocopherol is also a powerful antioxidant that 
has been used to enhance the effect of other 
substances against myeloma, ovarian, and breast 
cancer cells (Diaz et al., 2005, Zheng et al., 2012) 
and combining it with Quercetin to achieve an 
enhanced toxicity against breast and ovarian 
cancer cells is an innovation of this study. To 
measure the effects of these combinations we 
evaluated cell viability, incidence of apoptosis and 
necrosis and proliferation.
MATERIALS AND METHODS
Cell culture, chemicals and media
Human ovarian carcinoma cells from the 
A2780 line, and human mammary gland carcinoma 
cells belonging to the T47D-KBluc line were were 
obtained from American Type Culture Collection 
(ATCC, USA). All chemicals were purchased from 
Sigma-Aldrich unless otherwise specified.
Human cancer cells A2780 and T47D-KBluc 
were cultured in RPMI-1640 supplemented with 
2 mM L-glutamine, 10% fetal bovine serum, 
100 IU/ml penicillin (Intervet) and 100 µg /ml 
streptomycin (Intervet).
Trolox (6-hydroxy-2,5,7,8-tetramethyl-
3,4-dihydrochromene-2-carboxylic acid) and 
Quercetin (3,3′,4′,5,7-pentahydroxyflavone) were 
dissolved separately in 95% ethanol to prepare 
stock solutions. These were added to the culture 
medium in the following concentrations: 50µM 
Trolox (50T), 50µM Trolox + 25 µM Quercetin 
(50T+25Q), 50µM Trolox + 50 µM Quercetin 
(50T+50Q), 50µM Trolox + 100 µM Quercetin 
(50T+100Q). Two controls were added to the 
experiment, one supplemented with 0.45% 
ethanol 95% (Ctrl1) to test ethanol toxicity and 
one to which no addition had been made (Ctrl). 
Viability assay
Cells belonging to the A2780 and T47D-
KBluc lines were seeded in 25cm² flasks allowed 
to adhere to the substrate within the space of 24 
hours, and afterwards medium supplemented with 
the treatments was added. After being incubated 
with the various treatments for 24 hours, cell 
viability was analysed by staining with trypan 
blue. This vital stain enters dead cells making 
them appear dark blue and easy to differentiate 
from live cells that are light blue or transparent. 
Briefly, cells were harvested using trypsin and cell 
suspension mixed with trypan blue was loaded 
into a Bürker-Türk chamber. Live versus dead cells 
were counted and concentrations were computed 
using the formula below.
C = DSH
N
n
×××                       (1)
Where: C – concentration per ml;
n – number of counted cells;
N – number of squares from which cells were 
counted;
H – height of the chamber (10 µm);
S – surface of a square (1000 µm2);
D – dilution (100).
Concentrations of live and dead cells were used to 
compute percentages for both categories.
Apoptosis and necrosis assay
Tumour cells were seeded in 35 mm Petri 
dishes containing sterile coverslips. Cells were 
allowed to adhere to the coverslips within the 
space of 24 hours, and afterwards medium 
supplemented with the treatments was added. 
After being incubated with the various treatments 
for 24 hours, coverslips with cells were washed with 
PBS and exposed to a mixture of Hoechst 33258 
(20 µg/ml) and propidium iodide (50 µg/ml) for 
10 minutes. Coverslips were mounted on glass 
slides and cells were analysed immediately using 
an Olympus BX51 epifluorescence microscope 
(Brady, 2004; Rahman et al., 2013). A minimum of 
200 cells were counted and the number of cells for 
each cellular state was recorded. The percentages 
of apoptotic and necrotic cells were determined 
according to the following formulas (Brady, 2004):
(2)
(3)
 
Percentage of Apoptotic Cells (%) = 100)( ×
+++
+
DADNLALN
DALA
 
 
Percentage of Necrotic Cells (%) = 100×
+++ DADNLALN
DN     
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Where LN – live cells with normal nuclei (blue 
chromatin with organized structure);
LA – live cells with apoptotic nuclei (bright 
blue chromatin that is highly condensed or 
fragmented);
DN – dead cells with normal nuclei (pink chromatin 
with organized structure);
DA – dead cells with apoptotic nuclei (bright pink 
or red chromatin that is, highly condensed or 
fragmented).
Cell proliferation and activity assay
The effect of Trolox and Quercetin combinations 
was measured by the MTT (2-(4,5-dimethyl-2-
thiazolyl)-3,5-diphenyl-2H-tetrazolium bromide) 
assay adapted from Mosmann (1983). Cells from 
the A2780 and T47D-KBluc lines were plated in 96-
well plates and cultured for 24 hours. Afterwards, 
medium was replaced with RPMI-1640 containing 
the treatments, and cells were incubated for an 
additional 24 hours. MTT dissolved in PBS (0.5 
mg/ml) was added to each well (150 μl/well) and 
cells were further incubated at 37o C for 2 hours. 
During this time, MTT was reduced by enzymes of 
live cell to a purple formazan product which was 
afterward, dissolved by adding 150 µl/well DMSO. 
Then it was analysed by using a Synergy 2 Multi-
Mode Reader (BioTek) to measure absorbance 
at 550 nm and 630 nm. The percentage of cell 
viability was calculated according to the following 
equation:
Cell activity (%) =
100
630550
630550 ×
−
−
ControlAControlA
TreatmentATreatmentA  
 (4)
Where: Treatment A
550
 – absorbance at 550 nm for 
each treatment;
Treatment A
630
 – absorbance at 6300 nm for each 
treatment;
Control A
550
 – absorbance at 550 nm for the 
control;
Control A
630
 – absorbance at 650 nm for the control.
Statistical analysis
The experiments were conducted in 
triplicates. For all experiments, one-way ANOVA 
with the Tukey-Kramer post-test was performed 
using GraphPad InStat version 3.05 for Windows 
95 (GraphPad Software, San Diego California, 
USA). The values were considered statistically 
significant when p < 0.05.
RESULTS AND DISCUSSION
The working hypothesis was tested by 
assessing cell viability, incidence of apoptosis and 
necrosis and proliferation.
Cell viability was estimated using the trypan 
blue dye which penetrates dead cells but is 
excluded by living ones.  After incubation with 
Trolox and Quercetin, the viability of cells from the 
A2780 line decreased in a progressive manner as 
the flavonoid concentration increased, but without 
statistically significant differences (Tab. 1). The 
two tested substances had a marked influence 
on the viability of T47D-KBluc cells, which was 
significantly lower for those incubated with 50 µM 
Trolox and 25 µM Quercetin.
The incidence of apoptosis and necrosis was 
assessed by staining with Hoechst 33258 and 
propidium iodide. These are fluorescent dyes that 
enter the cell and allow differentiating between 
normal live cells, cells undergoing apoptosis that 
have blue chromatin and dead cells or cells with a 
damaged membrane that are progressing through 
necrosis and have bright pink or red chromatin.
For cells from the A2780 line (Tab. 2), apoptosis 
was significantly increased by the presence of 
either 50 µM Trolox + 25µM Quercetin or 50 µM 
Trolox + 50 µM Quercetin in the culture media. 
On the other hand, the incidence of necrosis was 
not significantly altered by any of the treatments 
when compared with the control.
When we analysed results for the T47D-KBluc 
line (Tab. 3), the situation was reversed with the 
percentage of necrotic cells being significantly 
increased by the addition of 50 µM Trolox + 100 
µM Quercetin to the culture media.
Cell proliferation was assessed by the 
MTT assay in which the dye is reduced by 
NAD(P)H-dependent oxidoreductases and 
dehydrogenases of metabolically active cells. This 
process is associated not only with mitochondria, 
but also with the cytoplasm (Berridge et al., 2005). 
Therefore, this assay measures enzyme activity in 
the analysed population of cells.
When A2780 cells were analysed (Tab. 4), 
enzyme activity was significantly enhanced by the 
185
Bulletin UASVM Animal Science and Biotechnologies 72(2) / 2015
combination of 50 µM Trolox + 25 µM Quercetin. 
The same mix increased (𝑃 < 0.05) enzyme activity 
in T47D-KBluc cells with the 50 µM Trolox having 
a similar effect. An interesting development was 
the marked decrease (𝑃 < 0.05) in cell metabolism 
induced by 50 µM Trolox + 100 µM Quercetin.
Quercetin has been found to inhibit the growth 
of pancreatic cancer cells both in vivo and in vitro 
(Angst et al., 2013). It has also been found that its 
anticancer activity against leukaemia cells can be 
enhanced by certain water-soluble antioxidants 
(Chen et al., 2004). In erythroleukemia cells, 
concentrations above 100 µM are toxic, while 
those below this limit increase viability (Akan and 
Garip, 2013). A similar effect, but with a threshold 
level of 40 µM has been observed in ovarian 
cancer cells, if Quercetin was combined with 
anti-neoplastic agents such as Cisplatin, Taxol, 
Pirarubicin and 5-Fluorouracil (Maciejczyk and 
Surowiak, 2013; Li et al., 2014). In other studies, 
Quercetin inhibited the growth of breast cancer 
cells. The mechanism behind this effect could be 
the induction of apoptosis by triggering G0/G1 
phase arrest (Deng et al., 2013).
Our results show that the response of cells 
to Trolox and Quercetin combinations depends 
on their type. These substances and particularly 
the 50 µM Trolox + 25µM Quercetin mix induced 
apoptosis in cells form the A2780 line without 
influencing viability. However, enzyme activity in 
these cells was significantly increased.
Conversely, in T47D-KBluc cells necrosis was 
enhanced by supplementation with 50 µM Trolox 
+ 100 µM, a combination that also decreased the 
percentages of metabolically active cells. Together 
with this concentration, a mix made of 50 µM 
Trolox and 25 µM Quercetin reduced cell viability.
Apoptosis is a highly organized and 
coordinated form of cell death, which requires 
energy supplied by mitochondria under the form 
of ATP (Borutaite, 2010). It has been described as 
an active process (Gogvadze and Orrenius, 2006) 
and therefore enzyme activity in these cells is 
increased. These mechanisms are apparent in the 
case of A2780 ovarian cancer cells, which have 
a higher mitochondrial activity in the presence 
of certain Trolox and Quercetin concentrations. 
The apoptosis process is characterized by cell 
Tab. 1. Percentages of live cells after incubation with Trolox and Quercetin
Treatment A2870 T47D-Kbluc
Ctrl 84.77 ± 0.42 a 77.75 ± 1.25 a
Ctrl1 84.50 ± 2.46 a 76.65 ± 3.95 a
50T 84.03 ± 2.11 a 75.80 ± 0.20 ac
50T + 25Q 84.63 ± 1.13 a 55.15 ± 5.15 b
50T + 50Q 83.43 ± 1.49 a 63.25 ± 0.75 abc
50T + 100Q 80.20 ± 4.45 a 66.75 ± 1.45 abc
Note: Values expressed are mean ± standard error of the mean (SEM) of triplicate measurements. Different 
letters between means within the same column denote significant differences (𝑃 < 0.05). Medium in Ctrl1 
was supplemented with 0.45% ethanol 95%.
Tab. 2. Percentages of apoptotic and necrotic cells from line A2780 after 
incubation with Trolox and Quercetin
Treatment Apoptotic cells (%) Necrotic cells (%)
Ctrl 37.00 ± 4.33 a 39.60 ± 7.07 ab
Ctrl1 45.16 ± 2.42 ad 34.50 ± 1.80 ab
50T 42.30 ± 0.19 ad 38.46 ± 0.57 ab
50T + 25Q 58.00 ± 0.50 bc 27.50 ± 1.04 a
50T + 50Q 49.00 ± 0.57 bcd 37.00 ± 1.04 ab
50T + 100Q 46.00 ± 0.50 a 46.16 ± 0.88 b
Note: Values expressed are mean ± standard error of the mean (SEM) of triplicate measurements. Different 
letters between means within the same column denote significant differences (𝑃 < 0.05). Medium in Ctrl1 
was supplemented with 0.45% ethanol 95%.
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shrinkage, chromatin condensation, nuclear and 
cytoplasmic fragmentation and preservation of the 
plasma membrane barrier (Elmore, 2007). This 
makes it impossible for trypan blue and propidium 
iodide to enter the apoptotic cell (Nieminen, 
2003) which can account for A2780 cell viability 
decreasing only slightly in the presence of the 
investigated substances.In contrast to apoptosis, necrosis is a passive 
form of cell death (Gogvadze and Orrenius, 2006). 
Its distinctive features include mitochondrial 
depolarization and depletion of intracellular 
ATP, generation of reactive oxygen species and 
ultimately the collapse of the plasma membrane 
barrier. These events make possible the entrance 
of chemicals such as trypan blue and propidium 
iodide (Herman et al, 1988; Zong and Thompson, 
2006). This could be the reason for the drop in 
cellular enzyme activity measured by MTT coupled 
with a higher incidence of necrosis encountered 
when 50 µM Trolox + 100 µM Quercetin were 
added to the culture medium of T47D-KBluc cells.
It is known that apoptosis and necrosis can be 
initiated in response to the same types of insults 
with different doses or intensities (Zong and 
Thompson, 2006). Our research indicates that 
in combination with Trolox low concentrations 
of Quercetin induce apoptosis in ovarian cancer 
cells while high concentrations induce necrosis in 
breast cancer cells. In both cell types, combinations 
of Trolox and Quercetin gave significantly better 
results than Trolox alone. 
CONCLUSION
Experiments indicate that cells belonging to 
the human ovarian cancer cell line A2780 and the 
human breast cancer cell line T47Dkb-luc respond 
differently according to type to incubation 
with Trolox and Quercetin combinations. 
Quercetin concentrations influence this response 
significantly.
In the A2780 line 50 µM Trolox + 25µM 
Quercetin increased the number of apoptotic cells 
and enzyme activity in these cells. On the other 
hand, in the T47Dkb-luc line the 50 µM Trolox 
+ 100 µM combination enhanced necrosis and 
thus reduced the percentages of metabolically 
active cells. Combining Quercetin with Trolox 
Tab. 4. Effect of Trolox and Quercetin on cell activity
Treatment A2870 T47D-Kbluc
Ctrl 100.00 ± 0.00 a 100.00 ± 0.00 a
Ctrl1 109.86 ± 5.38 a 86.44 ± 2.89 b
50T 91.31 ± 3.21 a 123.73 ± 3.79 c
50T + 25Q 149.15 ± 5.89 b 124.26 ± 1.45 c
50T + 50Q 107.73 ± 5.58 a 99.95 ± 3.50 a
50T + 100Q 101.92 ± 7.66 a 86.33 ± 3.32 b
Note: Values expressed are mean ± standard error of the mean (SEM) of triplicate measurements. Different 
letters between means within the same column denote significant differences (𝑃 < 0.05). Medium in Ctrl1 
was supplemented with 0.45% ethanol 95%.
Tab. 3. Percentages of apoptotic and necrotic cells from line T47D-KBluc 
after incubation with Trolox and Quercetin
Treatment Apoptotic cells (%) Necrotic cells (%)
Ctrl 52.83 ± 4.84 a 28.50 ± 5.77 a
Ctrl1 47.50 ± 1.08 a 34.66 ± 1.30 ab
50T 58.33 ± 2.96 a 29.50 ± 3.05 a
50T + 25Q 54.00 ± 2.29 a 28.33 ± 3.18 a
50T + 50Q 48.16 ± 0.60 a 40.16 ± 0.88 ab
50T + 100Q 46.83 ± 1.59 a 45.83 ± 0.72 b
Note: Values expressed are mean ± standard error of the mean (SEM) of triplicate measurements. Different 
letters between means within the same column denote significant differences (𝑃 < 0.05). Medium in Ctrl1 
was supplemented with 0.45% ethanol 95%.
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can enhance their toxic activity against breast 
and ovarian cancer cells. Further research is still 
needed to explain the molecular mechanisms by 
which these processes take place in tumour cells.
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